Egrifta

Active Ingredient(s): Tesamorelin Acetate
FDA Approved: * November 10, 2010
Pharm Company: * THERATECHNOLOGIES
Category: HIV / AIDS

Growth hormone–releasing hormone (GHRH), also known as somatocrinin or by several other names in its endogenous forms and as somatorelin (INN) in its pharmaceutical form, is a releasing hormone of growth hormone (GH). It is a 44[1]-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus. GHRH first appears in the human hypothalamus between 18 and 29 weeks of gestation, which corresponds to the start of production of growth hormone and other somatot... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Egrifta Subcutaneous Kit
NDC: 44087-2010
Labeler:
Emd Serono, Inc.
Egrifta Subcutaneous Kit
NDC: 44087-2011
Labeler:
Emd Serono, Inc.
Egrifta Subcutaneous Kit
NDC: 62064-011
Labeler:
Theratechnologies Inc.
EgriftaEgrifta Subcutaneous Kit
NDC: 62064-041
Labeler:
Theratechnologies Inc.